Intranasal treatment device
The present invention relates to a closed system intranasal treatment device that is preferably in round, square, rectangular, triangular prism, quadrilateral, pentagon etc. form and that ensures the person who will use it gets maximum efficiency from the drug by creating a closed structure by completely wrapping noses of pediatric, adult and geriatric patient groups and preventing the drug from passing out of the system and maximizes patient compliance, in which all liquid pharmaceutical compositions in the state of the art are applicable.
1 . A closed system nasal treatment device for children and adults, that ensures a patient who will use it gets maximum efficiency from a drug by creating a closed structure by completely wrapping the nose of the patient and preventing the drug from passing out of the nasal treatment device and maximizes patient compliance, in which applicable to liquid pharmaceutical compositions, the nasal treatment device comprises:
a skeletal system ( 1 ), which has a structure configured to completely cover the nose of the patient;
a drug reservoir ( 2 ), which can be produced in the form of a tube or in different geometric shapes inside the nasal treatment device and filled with drugs in liquid form and which provides a soft mist aerosol;
a battery ( 3 ) or a cell battery that can be charged remotely via wired or wireless, which provides a power that a nebulizer ( 5 ) needs while working;
holes ( 4 ) that enable the incoming drug in liquid form to transform into the soft mist aerosol droplets with a desired particle ratio in a targeting region;
the nebulizer ( 5 ) which allows the liquid form in the drug reservoir ( 2 ) to become the soft mist aerosol droplets as it passes through the holes ( 4 );
a mobile phone configured to be a remote control ( 6 ) that allows the device to be controlled remotely;
software to be installed on the mobile phone that enables the nebulizer ( 5 ) to be operated with or without the battery ( 3 ), and to adjust the dose according to the age, height, and weight of the patient; and
ladybug wings ( 7 ) having a structure in the form of a shutter system that opens to an upper part of the skeletal system ( 1 ) during drug administration configured to close an outer wall of the skeletal system ( 1 ) and prevents the soft mist aerosol droplets released from the holes ( 4 ) from escaping out of the skeletal system ( 1 ).
2 . The nasal treatment device of claim 1 , wherein a shape of the skeletal system ( 1 ) is a round ball, a square, a rectangular, a triangular prism, a quadrilateral, or a pentagon.
3 . The nasal treatment device of claim 2 , wherein the shape of the skeletal system ( 1 ) is the round ball.
4 . The nasal treatment device of claim 1 , wherein the nasal treatment device is configured to be charged independent from the cell battery via the battery, wired or wirelessly.
5 . The nasal treatment device of claim 1 , wherein the nasal treatment device further comprises an activation button configured to target the drug into the nose.
6 . A method of operating the nasal treatment device of claim 5 , the method comprising:
turning on the nasal treatment device by activating the activation button;
ensuring communication between the mobile phone and the nasal treatment device via a Bluetooth unit, taking the height, weight, age, and/or gender information of the patient required to adjust the drug dose for the patient, and transmitting a trigger signal generated for this to a microprocessor unit;
processing of the trigger signal coming to the microprocessor unit by the microprocessor unit and determining a resonance frequency of a piezoelectric crystal material;
generating a signal from the determined resonance frequency by the microprocessor unit and transferring the signal to the piezoelectric crystal material by a driver circuit;
vibrating the piezoelectric crystal material; and
spraying the drug transformed into the soft mist aerosol droplets in a particle size according to the drug dose adjusted according to the height, weight, age, and/or gender information of the patient, through the holes ( 4 ) by triggering the drug reservoir ( 2 ) through the vibrating of the piezoelectric crystal material.
7 . An intranasal treatment device which ensures that a patient who will use it gets maximum efficiency from a drug by creating a closed structure by completely wrapping the nose of the patient and preventing the drug from passing out of the intranasal treatment device and maximizes patient compliance, in which applicable to liquid pharmaceutical compositions, the intranasal treatment device comprises:
a skeletal system ( 1 ), which has a structure configured to completely cover the nose of the patient;
a drug reservoir ( 2 ), which can be produced in the form of a tube or in different geometric shapes inside the intranasal treatment device and filled with drugs in liquid form and which provides a soft mist aerosol;
a piezoelectric crystal material located next to the drug reservoir ( 2 ) inside the skeletal system ( 1 );
a battery ( 3 ) or a cell battery that can be charged remotely via wired or wireless, which provides a power that a nebulizer ( 5 ) needs while working;
holes ( 4 ) that enable the incoming drug in liquid form to transform into the soft mist aerosol droplets with a desired particle ratio in a targeting region;
the nebulizer ( 5 ) which allows the liquid form in the drug reservoir ( 2 ) to become the soft mist aerosol droplets as it passes through the holes ( 4 ), operates the intranasal treatment device with a smart mobile device, and adjusts the dose according to the age, height, weight, and/or gender of the patient; and
ladybug wings ( 7 ), having a structure in the form of a shutter system that opens to an upper part of the skeletal system ( 1 ) during drug administration configured to close an outer wall of the skeletal system ( 1 ) and prevents the soft mist aerosol droplets released from the holes ( 4 ) from escaping out of the skeletal system ( 1 ).
8 . The intranasal treatment device of claim 7 , wherein the nebulizer ( 5 ) comprises a Bluetooth unit, a microprocessor unit, and a driver circuit, and wherein the nebulizer ( 5 ) is configured to trigger the piezoelectric crystal material by remote electromagnetic waves to adjust the dose and drug release according to the age, height, weight, and/or gender of the patient.
9 . The intranasal treatment device of claim 8 , further comprising smart mobile device, wherein the smart mobile device comprises a Bluetooth unit that allows the nebulizer ( 5 ) device to be controlled remotely and enables data communication between the smart mobile device and the intranasal treatment device.
10 . The intranasal treatment device of any one of claims 7-9 , further comprising an activation button.
11 . A method of operating the intranasal treatment device of claim 10 , the method comprising:
turning on the intranasal treatment device by activating the activation button;
ensuring communication between the smart mobile device and the intranasal treatment device via the Bluetooth unit, taking the height, weight, age, and/or gender information of the patient required to adjust the drug dose, and transmitting a trigger signal generated for this to the microprocessor unit;
processing the trigger signal coming to the microprocessor unit by the microprocessor unit and determining a resonance frequency of the piezoelectric crystal material;
generating a signal from the determined resonance frequency by the microprocessor unit and transferring the signal to the piezoelectric crystal material by the driver circuit;
vibrating the piezoelectric crystal material; and
spraying the drug transformed into the soft mist aerosol droplets in a particle size according to the drug dose adjusted according to the height, weight, age, and/or gender information of the patient through the holes ( 4 ) by triggering the medicine drug reservoir ( 2 ) through the vibrating the piezoelectric crystal material.